LOX-1 in atherosclerosis: biological functions and pharmacological modifiers

@article{Xu2012LOX1IA,
  title={LOX-1 in atherosclerosis: biological functions and pharmacological modifiers},
  author={Suowen Xu and Sayoko Ogura and Jiawei Chen and Peter J Little and Joel Moss and Peiqing Liu},
  journal={Cellular and Molecular Life Sciences},
  year={2012},
  volume={70},
  pages={2859-2872}
}
Lectin-like oxidized LDL (oxLDL) receptor-1 (LOX-1, also known as OLR-1), is a class E scavenger receptor that mediates the uptake of oxLDL by vascular cells. LOX-1 is involved in endothelial dysfunction, monocyte adhesion, the proliferation, migration, and apoptosis of smooth muscle cells, foam cell formation, platelet activation, as well as plaque instability; all of these events are critical in the pathogenesis of atherosclerosis. These LOX-1-dependent biological processes contribute to… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 57 extracted citations

LOX-1, OxLDL, and Atherosclerosis

Mediators of inflammation • 2013
View 7 Excerpts
Highly Influenced

PCSK9: A novel inflammation modulator in atherosclerosis?

Journal of cellular physiology • 2019
View 2 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 115 references

PPARgamma ligands inhibit TNF-alpha-induced LOX-1 expression in cultured endothelial cells.

Biochemical and biophysical research communications • 2001
View 5 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…